Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Researchers solve long-standing mystery linked to contraction of heart cells

Researchers solve long-standing mystery linked to contraction of heart cells

Carterra closes financing round for continued growth of the LSA platform for next generation antibody discovery

Carterra closes financing round for continued growth of the LSA platform for next generation antibody discovery

Nicoya raises $10 million in series a funding to make drug discovery digital

Nicoya raises $10 million in series a funding to make drug discovery digital

Patient-specific tumor organoids may one day be used to personalize cancer treatment

Patient-specific tumor organoids may one day be used to personalize cancer treatment

New technology systematically identifies drug targets in living animals

New technology systematically identifies drug targets in living animals

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Enterprise Therapeutics publishes open access paper on novel approach to treat cystic fibrosis

Enterprise Therapeutics publishes open access paper on novel approach to treat cystic fibrosis

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

New method for detection of microcystins and nodularin in human urine

New method for detection of microcystins and nodularin in human urine

Nicoya gains series A funding for digital drug discovery program

Nicoya gains series A funding for digital drug discovery program

Mayo Clinic launches Clinical Data Analytics Platform to improve the health of patients

Mayo Clinic launches Clinical Data Analytics Platform to improve the health of patients

Insilico Medicine to showcase results of generative biology target ID system

Insilico Medicine to showcase results of generative biology target ID system

SP Scientific launches the HT Series 3i Evaporators

SP Scientific launches the HT Series 3i Evaporators

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Insilico and Beiersdorf use next-generation AI technology in skin research

Insilico and Beiersdorf use next-generation AI technology in skin research

Boehringer Ingelheim to use PhoreMost's SITESEEKER platform in new collaboration

Boehringer Ingelheim to use PhoreMost's SITESEEKER platform in new collaboration

Structure of most lethal toxin produced by C. difficile bacteria identified

Structure of most lethal toxin produced by C. difficile bacteria identified

Scientists discover potential drug compounds that target common type of liver cancer

Scientists discover potential drug compounds that target common type of liver cancer

New 'tumor-on-a-chip' can be used to find better cancer fighting drugs

New 'tumor-on-a-chip' can be used to find better cancer fighting drugs

Combined datasets can expedite the discovery and development of new cancer drugs

Combined datasets can expedite the discovery and development of new cancer drugs